Characterization of the peptide-binding specificity of Mamu-B*17 and identification of Mamu-B*17-restricted epitopes derived from simian immunodeficiency virus proteins

Journal of Immunology

Volumn 169, Issue 1, 2002, Pages 210-219

  Mothé, Bianca R ^a   Sidney, John ^a   Dzuris, John L ^a   Liebl, Max E ^a   Fuenger, Sarah ^a   Watkins, David I ^a   Sette, Alessandro ^a  

^a Epimmune   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS PROTEIN; VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIGENICITY; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELLULAR IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; PATHOGENICITY; PEPTIDE ANALYSIS; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS CHARACTERIZATION; VIRUS REPLICATION;

EID: 0036644216     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.1.210     Document Type: Article

References (68)

1. Macaque models for AIDS vaccine development
2. Co-evolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses
3. Cytotoxic T lymphocytes specific for the simian immunodeficiency virus
4. T lymphocyte responses in HIV-infection: Implications for vaccine development
5. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
6. Isolation of an endogenously processed immunodominant viral peptide from the class I H-2Kb molecule
7. MHC ligands and peptide motifs: First listing
8. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules
9. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins
10. Definition of specific peptide motifs for four major HLA-A alleles
11. Several HLA alleles share overlapping peptide specificities
12. Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules
13. Prominent roles of secondary anchor residues in peptide binding to HLA-A24 human class I molecules
14. Two distinct HLA-A*0101-specific submotifs illustrate alternative peptide binding modes
15. Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules
16. Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules
17. Definition of the Mamu A*01 peptide binding specificity: Application to the identification of wild-type and optimized ligands from simian immunodeficiency virus regulatory proteins
18. + lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule Mamu-A*01: Implications for vaccine design and testing
19. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia
20. + T-cell function in mucosal and systemic compartments of simian immunodeficiency virus mac251- and simian-human immunodeficiency virus KU2-infected macaques
21. + T cells in the intestines of macaques during primary infection
22. Simian immunodeficiency virus evades a dominant epitope-specific cytotoxic T lymphocyte response through a mutation resulting in the accelerated dissociation of viral peptide and MHC class I
23. Simian immunodeficiency virus (SIV)-specific CTL are present in large numbers in livers of SIV-infected rhesus monkeys
24. Induction of AIDS virusspecific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen
25. The simian immunodeficiency virus envelope glycoprotein contains two epitopes presented by the Mamu-A*01 class I molecule
26. + cytotoxic T lymphocytes specific for dominant and nondominant viral epitopes in simian-human immunodeficiency virus-infected rhesus monkeys
27. Comparative analysis of cytotoxic T lymphocytes in lymph nodes and peripheral blood of simian immunodeficiency virus-infected rhesus monkeys
28. Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex
29. Cytotoxic T lymphocytes do not appear to select for mutations in an immunodominant epitope of simian immunodeficiency virus gag
30. Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus
31. Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen
32. Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infection
33. A high frequency of Mamu-A*01 in the rhesus macaque detected by polymerase chain reaction with sequence-specific primers and direct sequencing
34. SIV and SHIV CTL epitopes identified in macaques
35. Conserved MHC class I peptide binding motif between humans and rhesus macaques
36. A common rhesus macaque MHC class I molecule which binds a cytotoxic T-lymphocyte epitope in Nef of simian immunodeficiency virus
37. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules
38. Measurement of MHC/peptide interactions by gel filtration
39. Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef
40. Prominent roles of secondary anchor residues in peptide binding to HLA-A24 human class I molecules
41. Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules
42. Two complementary methods for predicting peptides binding major histocompatibility complex molecules
43. Several common HLA-DR types share largely overlapping peptide binding repertoires
44. ELISPOT assay to detect cytokine-secreting murine and human cells
45. Polymorphism in the α1 helix of the HLA-B heavy chain can have an overriding influence on peptide-binding specificity
46. Peptide motifs of HLA-B58, B60, B61, and B62 molecules
47. Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs
48. Identification of self peptides bound to purified HLA-B27
49. The three-dimensional structure of peptide-MHC complexes
50. Human cytotoxic T-lymphocyte repertoire to influenza A viruses
51. Human memory CTL response specific for influenza A virus is broad and multispecific
52. Escape of human immunodeficiency virus from immune control
53. Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi
54. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C
55. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients
56. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus: Identification of multiple epitopes and characterization of patterns of cytokine release
57. + T cells in hepatitis C virus-exposed healthy seronegative donors
58. Analysis of a successful immune response against hepatitis C virus
59. Hepatitis B virus immunopathogenesis
60. The evolving field of HIV CTL epitope mapping: New approaches to the identification of novel epitopes
61. Expression kinetics and subcellular localization of HIV-regulatory proteins Nef, Tat and Rev in acutely and chronically infected lymphoid cell lines
62. Identification of novel HLA-A2-restricted human immunodeficiency virus type-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype I peptide-binding motif
63. Human immunodeficiency virus type I Vif-mutant particles from restrictive cells: Role of Vif in correct particle assembly and infectivity
64. Vif is crucial for human immunodeficiency virus type I proviral DNA synthesis in infected cells
65. + T lymphocytes
66. Cytoskeleton association and virion incorporation of the human immunodeficiency virus type I Vif protein
67. HIV accessory proteins as therapeutic targets
68. Tatvaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication